BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31038354)

  • 1. Developmental Consequences of Prenatal Substance Use in Children and Adolescents.
    Guille C; Aujla R
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(7):479-486. PubMed ID: 31038354
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal and concurrent cocaine, alcohol, marijuana, and tobacco effects on adolescent cognition and attention.
    Singer LT; Min MO; Minnes S; Short E; Lewis B; Lang A; Wu M
    Drug Alcohol Depend; 2018 Oct; 191():37-44. PubMed ID: 30077054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Substance Use: Consequences, Identification, and Interventions.
    Chang G
    Alcohol Res; 2020; 40(2):06. PubMed ID: 32612898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal prenatal substance use and behavior problems among children in the U.S.
    Sen B; Swaminathan S
    J Ment Health Policy Econ; 2007 Dec; 10(4):189-206. PubMed ID: 18166830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance exposure in utero and developmental consequences in adolescence: a systematic review.
    Irner TB
    Child Neuropsychol; 2012; 18(6):521-49. PubMed ID: 22114955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: A review].
    Lamy S; Laqueille X; Thibaut F
    Encephale; 2015 Jun; 41 Suppl 1():S13-20. PubMed ID: 25439854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal use of illicit drugs, tobacco or alcohol and the risk of childhood cancer before 6 years of age.
    Auger N; Goudie C; Low N; Healy-Profitós J; Lo E; Luu TM
    Drug Alcohol Depend; 2019 Jul; 200():133-138. PubMed ID: 31129483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal cocaine exposure, child development, and the compromising effects of cumulative risk.
    Tronick EZ; Beeghly M
    Clin Perinatol; 1999 Mar; 26(1):151-71. PubMed ID: 10214547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal drug exposure: infant and toddler outcomes.
    Bandstra ES; Morrow CE; Mansoor E; Accornero VH
    J Addict Dis; 2010 Apr; 29(2):245-58. PubMed ID: 20407980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Licit and illicit substance use during pregnancy].
    Lamy S; Delavene H; Thibaut F
    Rev Prat; 2014 Mar; 64(3):317-20. PubMed ID: 24851359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview and epidemiology of substance abuse in pregnancy.
    Wendell AD
    Clin Obstet Gynecol; 2013 Mar; 56(1):91-6. PubMed ID: 23314721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine.
    Konijnenberg C; Sarfi M; Melinder A
    Early Hum Dev; 2016 Oct; 101():91-7. PubMed ID: 27614330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of maternal substance use during pregnancy on childhood outcome.
    Shankaran S; Lester BM; Das A; Bauer CR; Bada HS; Lagasse L; Higgins R
    Semin Fetal Neonatal Med; 2007 Apr; 12(2):143-50. PubMed ID: 17317350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal cocaine exposure: Direct and indirect associations with 21-year-old offspring substance use and behavior problems.
    Richardson GA; De Genna NM; Goldschmidt L; Larkby C; Donovan JE
    Drug Alcohol Depend; 2019 Feb; 195():121-131. PubMed ID: 30622013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.
    Lester BM; Tronick EZ; LaGasse L; Seifer R; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Lu J; Finnegan LP; Maza PL
    Pediatrics; 2002 Dec; 110(6):1182-92. PubMed ID: 12456917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnant women and mothers using alcohol, tobacco and illegal drugs].
    Nechanská B; Mravčík V; Sopko B; Velebil P
    Ceska Gynekol; 2012 Oct; 77(5):457-69. PubMed ID: 23116352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and alcohol drinking during pregnancy as the risk factors for poor child neurodevelopment - A review of epidemiological studies.
    Polańska K; Jurewicz J; Hanke W
    Int J Occup Med Environ Health; 2015; 28(3):419-43. PubMed ID: 26190723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal Substance Exposure: Associations with Neurodevelopment in Middle Childhood.
    Conradt E; McGrath M; Knapp E; Li X; Musci RJ; Mansolf M; Deoni S; Sathyanarayana S; Ondersma SJ; Lester BM;
    Am J Perinatol; 2024 May; 41(S 01):e1944-e1954. PubMed ID: 37164319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study.
    Covington CY; Nordstrom-Klee B; Ager J; Sokol R; Delaney-Black V
    Neurotoxicol Teratol; 2002; 24(4):489-96. PubMed ID: 12127894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.